Rukobia 600 mg/1
fostemsavir tromethamine · TABLET, FILM COATED, EXTENDED RELEASE · ViiV Healthcare Company
Rukobia is a tablet, film coated, extended release containing fostemsavir tromethamine at 600 mg/1, taken oral. Manufactured by ViiV Healthcare Company.
Key Facts
- Brand Name
- Rukobia
- Generic Name
- fostemsavir tromethamine
- NDC Code (Product)
49702-250- Manufacturer
- ViiV Healthcare Company
- Strength
- 600 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA212950
- Marketing Start
- 07/02/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Rukobia used for?
Rukobia contains fostemsavir tromethamine. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.
Is Rukobia a controlled substance?
Rukobia is not classified as a controlled substance by the DEA.
What is the generic name for Rukobia?
The generic name for Rukobia is fostemsavir tromethamine. There are no other listed brand versions of fostemsavir tromethamine.
What is the NDC code for Rukobia 600 mg/1?
The NDC (National Drug Code) for Rukobia 600 mg/1 is 49702-250, listed by ViiV Healthcare Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)